Eli Lilly rises after President Donald Trump announces a 100% tariff on drug products from companies not building manufacturing plants in the U.S. Sherwin-Williams Extends Losses. What’s Ailing the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback